Clinical Trial Update: Erythropoietin in Hemolytic Uremic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update on erythropoietin use for Hemolytic Uremic Syndrome and anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hemolytic Uremic Syndrome

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Hospital General de Niños Pedro de Elizalde | Conditions: Hemolytic-Uremic Syndrome, Anemia | Phase 4 | Status: COMPLETED